Nucleic Acids Research, 2003, Vol. 31, No. 2 596-601
© 2003 Oxford University Press
The pathogenic U3271C human mitochondrial tRNALeu(UUR) mutation disrupts a fragile anticodon stem
Department of Chemistry, Boston College, Merkert Chemistry Center, Chestnut Hill, MA 02467, USA
*To whom correspondence should be addressed. Tel: +1 617 552 3121; Fax: +1 617 552 0833; Email: shana.kelley{at}bc.edu
The U3271C mutation affecting the human mitochondrial transfer RNALeu(UUR) (hs mt tRNA) is correlated with diabetes and mitochondrial encephalopathies. We have explored the relationship between the structural effects of this mutation and its impact on function using chemical probing experiments and in vitro aminoacylation assays to investigate a series of tRNA constructs. Chemical probing experiments indicate that the U3271C substitution, which replaces an AU pair with a CA mispair, significantly destabilizes the anticodon stem. The introduction of a compensatory A3261G mutation reintroduces base pairing at this site and restores the structure of this domain. In fact, the anticodon stem of the A3261G/U3271C mutant appears more structured than wild-type (WT) hs mt tRNALeu(UUR), indicating that the entirely AU stem of the native tRNA is intrinsically weak. The results of the chemical probing experiments are mirrored in the aminoacylation activities of the mutants. The U3271C substitution decreases aminoacylation reactivity relative to the WT tRNA due to an increase in Km for the pathogenic mutant. The binding defect is a direct result of the structural disruption caused by the pathogenic mutation, as the introduction of the stabilizing compensatory mutation restores aminoacylation activity. Other examples of functional defects associated with the disruption of weak domains in hs mt tRNAs have been reported, indicating that the effects of pathogenic mutations may be amplified by the fragile structures that are characteristic of this class of tRNAs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Helm Post-transcriptional nucleotide modification and alternative folding of RNA Nucleic Acids Res., February 1, 2006; 34(2): 721 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mollers, K. Maniura-Weber, E. Kiseljakovic, M. Bust, A. Hayrapetyan, M. Jaksch, M. Helm, R. J. Wiesner, and J.-C. von Kleist-Retzow A new mechanism for mtDNA pathogenesis: impairment of post-transcriptional maturation leads to severe depletion of mitochondrial tRNASer(UCN) caused by T7512C and G7497A point mutations Nucleic Acids Res., September 30, 2005; 33(17): 5647 - 5658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kirino, Y.-i. Goto, Y. Campos, J. Arenas, and T. Suzuki Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease PNAS, May 17, 2005; 102(20): 7127 - 7132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. ROY, L. M. WITTENHAGEN, and S. O. KELLEY Structural probing of a pathogenic tRNA dimer RNA, March 1, 2005; 11(3): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kirino, T. Yasukawa, S. Ohta, S. Akira, K. Ishihara, K. Watanabe, and T. Suzuki Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease PNAS, October 19, 2004; 101(42): 15070 - 15075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Levinger, M. Morl, and C. Florentz Mitochondrial tRNA 3' end metabolism and human disease Nucleic Acids Res., October 11, 2004; 32(18): 5430 - 5441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. SISSLER, M. HELM, M. FRUGIER, R. GIEGE, and C. FLORENTZ Aminoacylation properties of pathology-related human mitochondrial tRNALys variants RNA, May 1, 2004; 10(5): 841 - 853. [Abstract] [Full Text] [PDF]
|
|